ozone application linked to sharp drop in nerve pain scores in postherpetic neuralgia study
Ozone therapy (MAH and subcutaneous injection) was effective or better in 93.4% of 30 PHN patients, with average pain score (VAS) reducing from 10 to 1.3 after an average of 39 treatments over 109 days.
What this means for you
Persistent nerve pain — the kind that lingers after a shingles outbreak — can be one of the hardest discomforts to manage. In this study, pain scores fell from a 10 to just 1.3 on average over a course of sessions, with over 93% of participants reporting meaningful relief. For anyone dealing with chronic nerve sensitivity, that kind of response points to real potential for day-to-day comfort and quality of life.
The published research
Efficacy of Ozone Therapy on Postherpetic Neuraligia (PHN)
· 2005
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.